SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011877
Filing Date
2018-08-14
Accepted
2018-08-14 17:02:45
Documents
28
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10-q.htm 10-Q 195015
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11397
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4754
  Complete submission text file 0001493152-18-011877.txt   711152

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lwel-20180630.xml EX-101.INS 43783
5 XBRL SCHEMA FILE lwel-20180630.xsd EX-101.SCH 10059
6 XBRL CALCULATION FILE lwel-20180630_cal.xml EX-101.CAL 15764
7 XBRL DEFINITION FILE lwel-20180630_def.xml EX-101.DEF 20886
8 XBRL LABEL FILE lwel-20180630_lab.xml EX-101.LAB 63896
9 XBRL PRESENTATION FILE lwel-20180630_pre.xml EX-101.PRE 52605
Mailing Address ONE INTERNATIONAL PLACE, SUITE 1400 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE, SUITE 1400 BOSTON MA 02110 (281) 668-2666
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 181018658
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1